Fasting and Post-Calcium Load Serum Calcium, Parathyroid Hormone, Calcitonin, in Male Idiopathic Calcium Urolithiasis - Evidence for a Basic Disturbance in Calcium Metabolism

2009 ◽  
Vol 90 (04) ◽  
pp. 71-75 ◽  
Author(s):  
P. O. Schwille ◽  
G. Rümenapf ◽  
J. Schmidtler ◽  
R. Köhler
1960 ◽  
Vol 199 (5) ◽  
pp. 851-855 ◽  
Author(s):  
Marshall R. Urist ◽  
Nancy M. Deutsch ◽  
George Pomerantz ◽  
Franklin C. McLean

The level of calcium was measured in whole serum and ultrafiltrates of serum of roosters and laying hens following parathyroidectomy or after treatment with parathyroid extract, and in the presence or absence of the effects of endogenous or exogenous estrogens. The results were correlated with changes in: a) the weight of various endocrine organs influencing calcium metabolism in avian species, and b) microradiographic and histologic sections of the bones. The parathyroid hormone and estrogen had an additive effect upon the serum calcium, rather than a synergistic action. The effect of each hormone was readily distinguished by the interpretation that while ultrafilterable calcium was under parathyroid control, the large increase in the nonultrafilterable fraction under the influence of estrogen depended upon the formation of a calcium phosphoproteinate complex the liver. Under all conditions, the interrelations between the ultrafilterable and the nonultrafilterable fractions of the serum calcium were those dependent upon a mass-law equilibrium.


1960 ◽  
Vol XXXIII (III) ◽  
pp. 317-346 ◽  
Author(s):  
B.-A. Lamberg ◽  
R. Gordin ◽  
B. Kuhlbäck ◽  
G. Björkenheim

ABSTRACT The purpose of this study was to investigate the tetanic predisposition and certain aspects of calcium metabolism in cases showing a vague disease picture, characterized mainly by the presence of visceral pains of unknown etiology, headaches, various neurovegetative symptoms, etc. The development of typical carpal cramps in Trousseau's or Trousseau-von Bonsdorff's test was regarded as a sign of a tetanic predisposition. In a total of several hundred cases of the type described above in which provocation tests were performed, the response was positive in 97. Spontaneous tetanic attacks occurred in 38 cases. On the basis of the calcium level the cases were classified in hypocalcaemic (20) and normocalcaemic (77). The latter were further divided into the following subgroups: cases with a history of thyroidectomy (7), neurogenous cases in which the disease picture was dominated by neurovegetative symptoms (26), idiopathic (42) and gastro-enterogenous (2). In addition, 18 cases of postoperative hypocalcaemic hypoparathyroidism were investigated in which the provocation test was positive in 16 and negative in two, notwithstanding a low serum calcium level. In this group spontaneous attacks occurred in 10 cases. Furthermore, in studies concerning calcium metabolism 41 control cases were used. In addition, Trousseau-von Bonsdorff's test was performed on 40 healthy subjects, all of whom responded negatively. The present investigation included determination of serum calcium and serum phosphorus and the excretion of calcium and phosphorus in the urine, intravenous calcium tolerance tests, parathyroid hormone tolerance tests and short-term AT 10 treatment for test purposes. This study was aided by a grant from the State Commission for Natural Sciences. The calcium excretion was less than 50 mg in practically all cases showing hypoparathyroidism, but also in one control case. In addition, an excretion of less than 50 mg a day was observed in one case of sprue and in one case of idiopathic tetany. The responses to the intravenous calcium tolerance test showed a wide variation, and it was concluded that this test is inadequate as an ordinary clinical routine test. The parathyroid hormone tolerance test gave a pathological response twice in one patient with postoperative hypoparathyroidism and in one case with normocalcaemia and a history of thyroidectomy. In many cases AT 10 therapy brought about a rapid and marked increase in calciuria, an excretion of as much as 800 mg a day being sometimes noted, although the changes in the blood were slight. This discrepancy in the response is emphasized and checking of the excretion of calcium, in addition to checking of the blood calcium, during AT 10 therapy is recommended. The clinical significance of the tetanic syndrome is discussed. In many cases the syndrome manifests itself only occasionally and under certain circumstances, but in others it may be grave enough to be called a disease. Patients with postoperative hypoparathyroidism constitute a separate group, in which the pathogenetic background seems to be clear. But it should be emphasized that there also are cases of postoperative hypoparathyroidism in which no signs of a tetanic predisposition can be elicited even by provocation. Latent tetany often seems to be associated with a vague disease picture. For the detection of a tetanic predisposition Trousseau-von Bonsdorff's test is very valuable. It may be added that during intravenous administration of calcium, exogenous 32P was found to be excreted in the urine in a different way than endogenous phosphorus.


1970 ◽  
Vol 65 (3) ◽  
pp. 401-408 ◽  
Author(s):  
O. Helmer Sørensen

ABSTRACT Calcitonin is capable of completely suppressing the hypercalcaemic effect of parathyroid hormone but not irreversibly. The parathyroid hormone extract used was the commercial preparation Para-Thor-Mone® (Lilly). When injected simultaneously, the parathyroid hormone had no influence on the hypocalcaemia induced by calcitonin one hour after the injection. The parathyroid hormone produced a hypercalcaemia of up to 42 h duration in rats without thyroids. If the thyroid gland was present the serum calcium did not exceed 5.5 mEq./l, probably because of an increased secretion of calcitonin. A transitory hypercalcaemia followed by a hypocalcaemia was seen in intact rats after an intraperitoneal calcium load. The hypocalcaemia could be explained by the counteracting secretion of calcitonin.


1974 ◽  
Vol 75 (2) ◽  
pp. 286-296 ◽  
Author(s):  
J. H. Lockefeer ◽  
W. H. L. Hackeng ◽  
J. C. Birkenhäger

ABSTRACT In 22 of 28 cases of primary hyperparathyroidism (PHP) the rise in the serum immunoreactive parathyroid hormone (IRPTH or PTH) level observed in response to lowering of the serum calcium by EDTA, exceeded that obtained in 8 control subjects. In 5 of these 22 patients who were studied again after parathyroidectomy the supranormal response was abolished. Fifteen of these 22 hyper-responsive PHP patients had basal IRPTH levels not exceeding the highest level in the controls and that of other groups of patients investigated (idiopathic hypercalciuria, non-parathyroid hypercalcaemia, operated PHP). Fourteen of the 22 hyper-reactive patients with PHP did not show hypocalcaemia during the infusion of EDTA. The extent of the release of PTH elicited by EDTA in cases of PHP does not as yet allow a prediction of the amount of pathological parathyroid tissue present, although all the PHP patients showing a normal release of PTH had a relatively small mass of parathyroid tissue (up to about 1 g) subsequently removed. In 9 cases of nephrolithiasis (8 of whom had idiopathic hypercalciuria) and in 7 cases of non-parathyroid hypercalcaemia, a normal PTH release was found.


1988 ◽  
Vol 117 (4_Suppl) ◽  
pp. S64-S65
Author(s):  
K. KRUSE ◽  
U. KRACHT ◽  
K. WOHLFART ◽  
U. KRUSE

2019 ◽  
Author(s):  
Saba Hafeez ◽  
Muhammad Saad ◽  
Hajira Ilyas ◽  
Aisling Smith ◽  
Anand Velusamy ◽  
...  

Author(s):  
Stefania Sella ◽  
Luciana Bonfante ◽  
Maria Fusaro ◽  
Flavia Neri ◽  
Mario Plebani ◽  
...  

AbstractObjectivesKidney transplant (KTx) recipients frequently have deficient or insufficient levels of serum vitamin D. Few studies have investigated the effect of cholecalciferol in these patients. We evaluated the efficacy of weekly cholecalciferol administration on parathyroid hormone (PTH) levels in stable KTx patients with chronic kidney disease stage 1–3.MethodsIn this retrospective cohort study, 48 stable KTx recipients (37 males, 11 females, aged 52 ± 11 years and 26 months post-transplantation) were treated weekly with oral cholecalciferol (7500–8750 IU) for 12 months and compared to 44 untreated age- and gender-matched recipients. Changes in levels of PTH, 25(OH) vitamin D (25[OH]D), serum calcium, phosphate, creatinine and estimated glomerular filtration rate (eGFR) were measured at baseline, 6 and 12 months.ResultsAt baseline, clinical characteristics were similar between treated and untreated patients. Considering the entire cohort, 87 (94.6%) were deficient in vitamin D and 64 (69.6%) had PTH ≥130 pg/mL. Serum calcium, phosphate, creatinine and eGFR did not differ between groups over the follow-up period. However, 25(OH)D levels were significantly higher at both 6 (63.5 vs. 30.3 nmol/L, p < 0.001) and 12 months (69.4 vs. 30 nmol/L, p < 0.001) in treated vs. untreated patients, corresponding with a significant reduction in PTH at both 6 (112 vs. 161 pg/mL) and 12 months (109 vs. 154 pg/mL) in treated vs. untreated patients, respectively (p < 0.001 for both).ConclusionsWeekly administration of cholecalciferol can significantly and stably reduce PTH levels, without any adverse effects on serum calcium and renal function.


Rheumatology ◽  
2021 ◽  
Vol 60 (Supplement_1) ◽  
Author(s):  
Mahrukh Khalid ◽  
Vismay Deshani ◽  
Khalid Jadoon

Abstract Background/Aims  Vitamin D deficiency is associated with more severe presentation of primary hyperparathyroidism (PTHP) with high parathyroid hormone (PTH) levels and reduced bone mineral density (BMD). We analyzed data to determine if vitamin D levels had any impact on PTH, serum calcium and BMD at diagnosis and 3 years, in patients being managed conservatively. Methods  Retrospective analysis of patients presenting with PHPT. Based on vitamin D level at diagnosis, patients were divided into two groups; vitamin D sufficient (≥ 50 nmol/L) and vitamin D insufficient (≤ 50 nmol/L). The two groups were compared for age, serum calcium and PTH levels at diagnosis and after mean follow up of 3 years. BMD at forearm and neck of femur (NOF) was only analyzed in the two groups at diagnosis, due to lack of 3 year’s data. Results  There were a total of 93 patients, 17 males, mean age 70; range 38-90. Mean vitamin D level was 73.39 nmol/L in sufficient group (n = 42) and 34.48 nmol/L in insufficient group (n = 40), (difference between means -38.91, 95% confidence interval -45.49 to -32.33, p &lt; 0.0001). There was no significant difference in age, serum calcium and PTH at the time of diagnosis. After three years, there was no significant difference in vitamin D levels between the two groups (mean vitamin D 72.17 nmol/L in sufficient group and 61.48 nmol/L in insufficient group). Despite rise in vitamin D level in insufficient group, no significant change was observed in this group in PTH and serum calcium levels. BMD was lower at both sites in vitamin D sufficient group and difference was statistically significant at NOF. Data were analyzed using unpaired t test and presented as mean ± SEM. Conclusion  50% of patients presenting with PHPT were vitamin D insufficient at diagnosis. Vitamin D was adequately replaced so that at 3 years there was no significant difference in vitamin D status in the two groups. Serum calcium and PTH were no different in the two groups at diagnosis and at three years, despite rise in vitamin D levels in the insufficient group. Interestingly, BMD was lower at forearm and neck of femur in those with sufficient vitamin D levels and the difference was statistically significant at neck of femur. Our data show that vitamin D insufficiency does not have any significant impact on PTH and calcium levels and that vitamin D replacement is safe in PHPT and does not impact serum calcium and PTH levels in the short term. Lower BMD in those with adequate vitamin D levels is difficult to explain and needs further research. Disclosure  M. Khalid: None. V. Deshani: None. K. Jadoon: None.


Sign in / Sign up

Export Citation Format

Share Document